BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23322448)

  • 1. In vitro cytokine release profile: predictive value for metastatic potential in head and neck squamous cell carcinomas.
    Shkeir O; Athanassiou-Papaefthymiou M; Lapadatescu M; Papagerakis P; Czerwinski MJ; Bradford CR; Carey TE; Prince ME; Wolf GT; Papagerakis S
    Head Neck; 2013 Nov; 35(11):1542-50. PubMed ID: 23322448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.
    O-charoenrat P; Rhys-Evans P; Eccles SA
    Cancer; 2001 Aug; 92(3):556-68. PubMed ID: 11505400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.
    Druzgal CH; Chen Z; Yeh NT; Thomas GR; Ondrey FG; Duffey DC; Vilela RJ; Ende K; McCullagh L; Rudy SF; Muir C; Herscher LL; Morris JC; Albert PS; Van Waes C
    Head Neck; 2005 Sep; 27(9):771-84. PubMed ID: 15920746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line.
    Bran G; Götte K; Riedel K; Hörmann K; Riedel F
    In Vivo; 2011; 25(4):579-84. PubMed ID: 21708999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
    Ninck S; Reisser C; Dyckhoff G; Helmke B; Bauer H; Herold-Mende C
    Int J Cancer; 2003 Aug; 106(1):34-44. PubMed ID: 12794754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
    Van Tubergen E; Vander Broek R; Lee J; Wolf G; Carey T; Bradford C; Prince M; Kirkwood KL; D'Silva NJ
    Cancer; 2011 Jun; 117(12):2677-89. PubMed ID: 21656745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
    Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.
    Arthur AE; Peterson KE; Shen J; Djuric Z; Taylor JM; Hebert JR; Duffy SA; Peterson LA; Bellile EL; Whitfield JR; Chepeha DB; Schipper MJ; Wolf GT; Rozek LS
    Cancer; 2014 Sep; 120(17):2704-12. PubMed ID: 24830761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation.
    de Sousa EA; Lourenço SV; de Moraes FP; Vartanian JG; Gonçalves-Filho J; Kowalski LP; Soares FA; Coutinho-Camillo CM
    Head Neck; 2015 Oct; 37(10):1410-6. PubMed ID: 24824527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels].
    Karcher J; Reisser C; Daniel V; Herold-Mende C
    HNO; 1999 Oct; 47(10):879-84. PubMed ID: 10550371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA
    Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of peripheral blood mononuclear cells to conditioned medium from cultured oral squamous cell carcinomas.
    França CM; Barros FM; Lotufo MA; Fernandes KP; Borra RC
    Braz Oral Res; 2011; 25(5):414-20. PubMed ID: 22031054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck.
    Lathers DM; Achille NJ; Young MR
    Hum Immunol; 2003 Dec; 64(12):1160-6. PubMed ID: 14630398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells.
    Czerwinski MJ; Desiderio V; Shkeir O; Papagerakis P; Lapadatescu MC; Owen JH; Athanassiou-Papaefthymiou M; Zheng L; Papaccio G; Prince ME; Papagerakis S
    Otolaryngol Head Neck Surg; 2013 Jul; 149(1):97-104. PubMed ID: 23558285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.